Fintel reports that on December 12, 2025, Jefferies initiated coverage of Moderna (NasdaqGS:MRNA) with a Hold recommendation.

Veritas In Silico Inc. ( ($JP:130A) ) has issued an update. Veritas In Silico has filed a substance patent application in Japan for a ...

Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "mRNA Synthesis and Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Application Area, Therapeutic Area and Key ...

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

The strategic use of certain ETFs can help investors turn unrealized stock-picking losses into tangible tax savings.

CHICAGO and MILWAUKEE and NEW YORK, Dec. 24, 2025 (GLOBE NEWSWIRE) -- YieldMax (R) ETFs today announced distributions for the YieldMax (R) Group 2 weekly pay ETFs.

A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing ...

Artificial intelligence represents the biggest technological upheaval to the world economy since the rise of the internet a quarter-century ago. It has brought trillions of dollars of investment and ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...

Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.